Skip to main content

Currently Skimming:

Appendix A: References
Pages 65-76

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 65...
... 2016. Physiologic frailty in nonelderly hematopoietic cell transplantation patients: Results from the Bone Marrow Transplant Survivor Study.
From page 66...
... 2007. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: Report from the Bone Marrow Transplant Survivor Study.
From page 67...
... 2019. Post-transplantation cyclophosphamide after allogeneic hematopoietic stem cell transplantation: Results of the prospective randomized HOVON-96 trial in recipients of matched related and unrelated donors.
From page 68...
... 2018. Evolution of body composition following autologous and allogeneic hematopoietic cell transplantation: Incidence of sarcopenia and association with clinical outcomes.
From page 69...
... 2019. Disability related to chronic graft-versus-host disease after alternative donor hematopoietic cell transplantation.
From page 70...
... 2016. Trajectories of quality of life after hematopoietic cell transplantation: Secondary analysis of Blood and Marrow Transplant Clinical Trials Network 0902 data.
From page 71...
... 2019. Functional and radiologic assessment of the brain after reduced intensity unrelated donor transplantation for severe sickle cell disease: Blood and Marrow Transplant Clinical Trials Network Study 0601.
From page 72...
... 2022. Randomized phase III BMT CTN trial of Calcineurin inhibitor-free chronic graft-versus-host disease interventions in myeloablative hematopoietic cell transplantation for hematologic malignancies.
From page 73...
... 2021. The effect of exercise and nutrition interventions on physical functioning in patients undergoing haematopoietic stem cell transplantation: A systematic review and meta-analysis.
From page 74...
... 2021. National Marrow Donor Program-sponsored multicenter, phase II trial of HLA-mismatched unrelated donor bone marrow transplantation using post transplant cyclophosphamide.
From page 75...
... 2010. Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: A report from the Bone Marrow Transplant Survivor Study.
From page 76...
... 2020. Conditional survival, cause-specific mortality, and risk factors of late mortality after allogeneic hematopoietic cell transplantation.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.